R James White - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R James White

Showing results (41-50 of 70) with videos related to

Pageof 7

Sort By:

Respiratory Medicine|February 8, 2022

Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertensionAkram Khan, R James White, Gisela Meyer, et al.

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 18, 2022

Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EVRaymond L Benza, Mardi Gomberg-Maitland, Harrison W Farber, et al.

Medrxiv : the Preprint Server for Health Sciences|September 26, 2025

Sensor Estimated Home 6-Minute Walk Distance and Cardiac Effort in Pulmonary Hypertension and Heart FailureDaniel Lachant, Nishit Agarwal, Kyle Norton, et al.

Circulation|January 12, 2013

Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trialZhi-Cheng Jing, Keyur Parikh, Tomas Pulido, et al.

The Lancet. Respiratory Medicine|August 23, 2021

Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trialStephan Rosenkranz, Jeremy Feldman, Vallerie V McLaughlin, et al.

Circulation|May 28, 2009

Tadalafil therapy for pulmonary arterial hypertensionNazzareno Galiè, Bruce H Brundage, Hossein A Ghofrani, et al.

Annals of the American Thoracic Society|September 8, 2023

Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association RegistryConnor Fling, Teresa De Marco, Noah A Kime, et al.

Pulmonary Circulation|July 7, 2017

Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulationFranck F Rahaghi, Jeremy P Feldman, Roblee P Allen, et al.

Circulation|March 11, 2009

G-protein-coupled receptor kinase interacting protein-1 is required for pulmonary vascular developmentJinjiang Pang, Ryan Hoefen, Gloria S Pryhuber, et al.

Cardiovascular Therapeutics|September 14, 2012

Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertensionRobert C Bourge, Victor F Tapson, Zeenat Safdar, et al.

Pageof 7

Search research articles

Showing results (41-50 of 70) with videos related to

Sort By:

Pageof 7

Respiratory Medicine|February 8, 2022

Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertensionAkram Khan, R James White, Gisela Meyer, et al.

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 18, 2022

Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EVRaymond L Benza, Mardi Gomberg-Maitland, Harrison W Farber, et al.

Medrxiv : the Preprint Server for Health Sciences|September 26, 2025

Sensor Estimated Home 6-Minute Walk Distance and Cardiac Effort in Pulmonary Hypertension and Heart FailureDaniel Lachant, Nishit Agarwal, Kyle Norton, et al.

Circulation|January 12, 2013

Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trialZhi-Cheng Jing, Keyur Parikh, Tomas Pulido, et al.

The Lancet. Respiratory Medicine|August 23, 2021

Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trialStephan Rosenkranz, Jeremy Feldman, Vallerie V McLaughlin, et al.

Circulation|May 28, 2009

Tadalafil therapy for pulmonary arterial hypertensionNazzareno Galiè, Bruce H Brundage, Hossein A Ghofrani, et al.

Annals of the American Thoracic Society|September 8, 2023

Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association RegistryConnor Fling, Teresa De Marco, Noah A Kime, et al.

Pulmonary Circulation|July 7, 2017

Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulationFranck F Rahaghi, Jeremy P Feldman, Roblee P Allen, et al.

Circulation|March 11, 2009

G-protein-coupled receptor kinase interacting protein-1 is required for pulmonary vascular developmentJinjiang Pang, Ryan Hoefen, Gloria S Pryhuber, et al.

Cardiovascular Therapeutics|September 14, 2012

Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertensionRobert C Bourge, Victor F Tapson, Zeenat Safdar, et al.

Pageof 7